We currently intend to focus on target businesses in the infrastructure, engineering and construction (“E&C”), industrial and renewables industries. Eric S. Rosenfeld, our Chief SPAC Officer, and David D. Sgro, our Vice Chairman of the Board, have led seven prior public blank check companies: (i) Arpeggio Acquisition Corporation, or “Arpeggio,” which raised $40.8 million in June 2004 and […]

We intend to focus our search for a target in Latin America, and more specifically in Brazil, and in sectors with technology-enabled transformations and strong growth potential in the region, including, but not limited to technology, healthcare, education services, consumer and retail, or the Target Sectors. (Incorporated in the Cayman Islands) (Note: Crescera Capital Acquisition […]

We currently intend to concentrate our efforts on identifying technology and financial services technology, or fintech, companies that power transformation and innovation. Our expertise lends itself well to pursuing platforms related to the financial services, real estate, insurance, ecommerce and related technology infrastructure sectors. We will seek to capitalize on the significant technology, financial services, […]

We will seek visionary founders leading technology-enabled platforms disrupting the traditional worlds of sports, health, wellness, food, commerce, and culture through their unique relationship with the consumer. (Incorporated in the Cayman Islands)  Our sponsor is a 50-50 partnership between Thirty Five Ventures, co-founded and led by NBA superstar Kevin Durant and entrepreneur Rich Kleiman, and […]

We intend to focus our search on a target that aligns with the background and experience of our sponsor in financial technology. We expect to focus primarily on companies that serve five primary sub-sectors of our market segment: Banking & Payments; Capital Markets; Data & Analytics; Insurance; and Investment Management. We seek financial technology companies […]

We intend to target life science companies in North America and Singapore with a particular emphasis on companies developing assets and next-generation platform technologies with broad applicability. Our sponsor is an affiliate of Accelerator Life Science Partners, a venture capital firm focused on building next-generation life science companies solving important healthcare needs with cutting-edge breakthroughs […]

We intend to search globally with a focus on targets in the healthcare industry. Our sponsor is an affiliate of M.S.Q. Ventures Inc (MSQ), a research-driven advisory firm with deep domain expertise in life sciences.  Our primary focus will be on the life sciences industry. We believe the life sciences industry represents an enormous and growing […]

We are a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. We are currently developing two preclinical drug candidates with the lead candidate expected to begin a Phase 1 clinical trial in the fourth quarter of 2021. NXP800, one of our lead preclinical drug […]

(Note: Chobani Inc. withdrew its IPO in an SEC document dated Sept. 2, 2022.) (Note: The Wall Street Journal and others estimate that Chobani could raise about $1.5 billion in its IPO. Chobani’s S-1 filing, dated Nov. 17, 2021, lists the standard $100 million “placeholder” amount for proceeds. Chobani filed a confidential IPO document on […]

We intend to focus on identifying high growth technology and consumer-exposed businesses with an enterprise value of at least $700 million in Central and Eastern Europe, Russia or the Commonwealth of Independent States (the “CIS”). (Incorporated in the Cayman Islands)  Riccardo Orcel, our CEO, has a successful track record of leadership as a senior executive in investment […]